Call Today: 1-888-278-7952
Book Free Consultation
| Follow us on |  |
 |
 |
Gastric Balloon Procedure
Patient EligibilityGroups which are most likely to benefit from the Gastric Balloon are:
- Patients with BMI of 27-35, with or without comorbidities who have achieved little or no sustained weight loss through dietary and/or other approaches
- Patients with BMI of 35-40 without comorbidities who refuse bariatric surgery or would benefit from a 'bridge' to bariatric surgery, while considering their options
- Patients who need cardiovascular, orthopaedic or other surgery but whose excessive weight puts them at risk and/or reduces their likelihood of a good outcome
Click here to determine your patient's BMI.
Ideal PatientGastric Balloon References:
1. Adams KF, et al., Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old. New England Journal of Medicine 2006; 355: 763-7782. Fried M, et al., Inter-disciplinary European guidelines on surgery of severe obesity. International Journal of Obesity 2007; 31: 569-577
3. Buchwald H. Consensus Conference Statement. Bariatric surgery for morbid obesity: Health implications for patients, health professionals, and third-party payers. Surgery for Obesity and Related Diseases 2005; 1: 371-381
4. Lau DCW for the Obesity Canada Clinical Practice Guidelines Steering Committee and Expert Panel. Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. Canadian Medical Association Journal 2007; 176; 1103-1106
5. National Institute for Health and Clinical Excellence. Clinical guideline 43. Obesity guidance on the prevention, assessment and management of overweight and obesity in adults and children, December 2006
6. Genco A, et al. BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients. Obesity Surgery 2005; 15: 1161-1164
7. Sallet JA, et al. Brazilian multicenter study of the intragastric balloon. Obesity Surgery 2004; 14:991-998
8. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19-27
9. Cobourn C. et al., Expert Approaches to Weight Loss Management, Issue 1, The Allergan ORBERA™ Managed Weight Loss System